PAPER Averaimo S, Milton RH, Duchen MR, Mazzanti M
SEARCH RESULTS
330026 RESULTS
PAPER Wiltshire KM, Dunham C, Reid S, Auer RN, Suchowersky O
Neuronal Intranuclear Inclusion Disease presenting as juvenile Parkinsonism.
Can J Neurol Sci. 2010 Mar;37(2):213-8. PubMed: 20437931PAPER Tagliari B, Noschang CG, Ferreira AG, Ferrari OA, Feksa LR, Wannmacher CM, Dalmaz C, Wyse AT
Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: prevention by chronic antioxidant treatment.
Metab Brain Dis. 2010 Jun;25(2):169-76. PubMed: 20505986Bruce Miller
United States
Erin Clarke
Canada
PAPER Ballard C, Jones EL, Londos E, Minthon L, Francis P, Aarsland D
alpha-Synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies.
Int Psychogeriatr. 2010 Mar;22(2):321-7. PubMed: 19747426PAPER Henrique D, Bally-Cuif L
A cross-disciplinary approach to understanding neural stem cells in development and disease.
Development. 2010 Jun;137(12):1933-8. PubMed: 20501588PAPER Warby SC, Visscher H, Butland S, Pearson CE, Hayden MR
Response to Falush: a role for cis-element polymorphisms in HD.
Am J Hum Genet. 2009 Dec;85(6):942-5. PubMed: 20004773PAPER Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, Simpson E, Harati Y, Strutt AM, York MK, Schulz PE
A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS.
Amyotroph Lateral Scler. 2010 Dec;11(6):542-8. PubMed: 20500116PAPER Xu X, Kedlaya R, Higuchi H, Ikeda S, Justice MJ, Setaluri V, Ikeda A
Mutation in archain 1, a subunit of COPI coatomer complex, causes diluted coat color and Purkinje cell degeneration.
PLoS Genet. 2010 May;6(5):e1000956. PubMed: 20502676PAPER Fu Q, Dai H, He P, Hu W, Fan Y, Zhang W, Chen Z
The H3 receptor antagonist clobenpropit protects against Abeta42-induced neurotoxicity in differentiated rat PC12 cells.
Pharmazie. 2010 Apr;65(4):257-60. PubMed: 20432621ApoE and Brain Networks—The Anatomy of a Risk Factor
RESEARCH NEWS 2010-05-28 Research News Clinicians have long puzzled over the heterogeneity of Alzheimer disease symptoms—for example, some patients display the classic disorientation and forgetfulness, whereas others struggle more with planning and organization. A PNAS paper publ
PAPER Jiao W, McDonald DQ, Coxon JM, Parker EJ
Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain.
Biochemistry. 2010 Jul 6;49(26):5533-9. PubMed: 20499928PAPER Alvarez XA, Cacabelos R, Sampedro C, Aleixandre M, Linares C, Granizo E, Doppler E, Moessler H
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.
Eur J Neurol. 2011 Jan;18(1):59-68. PubMed: 20500802PAPER Kornhuber J, Tripal P, Reichel M, Mühle C, Rhein C, Muehlbacher M, Groemer TW, Gulbins E
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications.
Cell Physiol Biochem. 2010;26(1):9-20. PubMed: 20502000Current Filters
No filters selected